BioCryst Pharmaceuticals Inc (BCRX) stock
BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.30−0.20 (-2.67%)
Close on Nov 18, 2026Market cap $1.87BP/E –Yield –
BioCryst Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BioCryst Pharmaceuticals's market cap was $1.95B on Nov 11, 2026, against $1.51B a year earlier. Over the last 5 years it ranged from $849.83M to $3.06B, with a median of $1.71B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.95B | +18.9% |
| 2025 | Dec 31, 2025 | $1.64B | +5.4% |
| 2024 | Dec 31, 2024 | $1.56B | +37.0% |
| 2023 | Dec 29, 2023 | $1.14B | -46.9% |
| 2022 | Dec 30, 2022 | $2.14B | -14.1% |
| 2021 | Dec 31, 2021 | $2.49B | +89.3% |
| 2020 | Dec 31, 2020 | $1.32B | +245.2% |
| 2019 | Dec 31, 2019 | $381.01M | -56.9% |
| 2018 | Dec 31, 2018 | $884.67M | +83.1% |
| 2017 | Dec 29, 2017 | $483.09M | +3.5% |
| 2016 | Dec 30, 2016 | $466.89M | -38.3% |
| 2015 | Dec 31, 2015 | $756.84M | -13.4% |
| 2014 | Dec 31, 2014 | $873.83M | +94.6% |
| 2013 | Dec 31, 2013 | $449.09M | +521.6% |
| 2012 | Dec 31, 2012 | $72.25M | +64621.2% |
| 2011 | Dec 30, 2011 | $111.63K | – |
See a number that looks wrong?